These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 17617603)

  • 1. TCR/CD28-stimulated actin dynamics are required for NFAT1-mediated transcription of c-rel leading to CD28 response element activation.
    Nolz JC; Fernandez-Zapico ME; Billadeau DD
    J Immunol; 2007 Jul; 179(2):1104-12. PubMed ID: 17617603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
    González E; Punzón C; González M; Fresno M
    J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors.
    Maggirwar SB; Harhaj EW; Sun SC
    Mol Cell Biol; 1997 May; 17(5):2605-14. PubMed ID: 9111330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL; Iacobelli M
    J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of the E3-ligase TRIM13 in NF-κB p65 activation and NFAT-dependent activation of c-Rel upon T-cell receptor engagement.
    Hatchi EM; Poalas K; Cordeiro N; N'Debi M; Gavard J; Bidère N
    Int J Biochem Cell Biol; 2014 Sep; 54():217-22. PubMed ID: 25088585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
    Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH
    Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T-cells.
    Tao L; Wadsworth S; Mercer J; Mueller C; Lynn K; Siekierka J; August A
    Biochem J; 2002 Apr; 363(Pt 1):175-82. PubMed ID: 11903060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a CD28 response element in the CD40 ligand promoter.
    Parra E; Mustelin T; Dohlsten M; Mercola D
    J Immunol; 2001 Feb; 166(4):2437-43. PubMed ID: 11160303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB.
    Kalli K; Huntoon C; Bell M; McKean DJ
    Mol Cell Biol; 1998 Jun; 18(6):3140-8. PubMed ID: 9584155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filamin A is required for T cell activation mediated by protein kinase C-theta.
    Hayashi K; Altman A
    J Immunol; 2006 Aug; 177(3):1721-8. PubMed ID: 16849481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Rel is required for chromatin remodeling across the IL-2 gene promoter.
    Rao S; Gerondakis S; Woltring D; Shannon MF
    J Immunol; 2003 Apr; 170(7):3724-31. PubMed ID: 12646638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2.
    Butscher WG; Powers C; Olive M; Vinson C; Gardner K
    J Biol Chem; 1998 Jan; 273(1):552-60. PubMed ID: 9417115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites.
    Shapiro VS; Truitt KE; Imboden JB; Weiss A
    Mol Cell Biol; 1997 Jul; 17(7):4051-8. PubMed ID: 9199340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional disparity of distinct CD28 response elements toward mitogenic responses.
    Civil A; Rensink I; Aarden LA; Verweij CL
    J Biol Chem; 1999 Nov; 274(48):34369-74. PubMed ID: 10567414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
    Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H
    J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.
    Tomkowicz B; Walsh E; Cotty A; Verona R; Sabins N; Kaplan F; Santulli-Marotto S; Chin CN; Mooney J; Lingham RB; Naso M; McCabe T
    PLoS One; 2015; 10(10):e0140694. PubMed ID: 26492563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65.
    Ghosh P; Tan TH; Rice NR; Sica A; Young HA
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1696-700. PubMed ID: 8383323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters.
    Himes SR; Coles LS; Reeves R; Shannon MF
    Immunity; 1996 Nov; 5(5):479-89. PubMed ID: 8934574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased c-rel activation contributes to aberrant interleukin-2 expression in CD4(+)T cells of aged rats.
    Gong Z; Liu T; Wan Y; Hang Z; Tong X; Zhang B; Yang H; Zhang X; Zhang L; Jin G
    Mol Immunol; 2014 Sep; 61(1):1-6. PubMed ID: 24853588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic regulation of Il2 transcription in CD4+ T cells: roles for TNF-alpha receptor signaling and chromatin structure.
    McKarns SC; Schwartz RH
    J Immunol; 2008 Jul; 181(2):1272-81. PubMed ID: 18606681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.